← Back to catalogue
ENHANCED Epithalon 50mg research compound
Longevity Research

Epithalon

50mg

Epithalon is a short synthetic peptide explored in research involving aging biology, cellular regulation and systemic resilience.

Research focusAging-biology and cellular-regulation research
PresentationLyophilised peptide · 50mg · 3 mL vial
ENQUIRE ABOUT THIS RESEARCH COMPOUND →

Research overview

Epithalon (Epitalon) is a short synthetic tetrapeptide associated with research into aging biology. Published work has explored cellular regulation, telomere-related questions and neuroendocrine models.

Evidence status

Limited experimental evidence

The evidence base is limited, with much of the literature originating from a relatively small research tradition. Claims about lifespan extension or rejuvenation are not established clinical conclusions.

Research use only. Not for human consumption. This page is educational and does not provide medical advice or dosing guidance.

Areas under investigation

  • Cellular aging research
  • Telomere-related experimental questions
  • Neuroendocrine and circadian models

Explore the scientific literature

For primary-source reading, search the indexed biomedical literature and registered clinical studies. These links are provided as research gateways rather than endorsements of any particular finding.

Explore related research